ArticleCells2022
Reticulocalbin 2 as a Potential Biomarker and Therapeutic Target for Atherosclerosis.
Jing Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleCells2022
Jing Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.